Medicare still won’t say how much covering obesity drugs will cost Eli Lilly and Novo Nordisk will likely get billions of dollars over the next 18 months

https://www.statnews.com/2026/06/01/medicare-50-dollar-weight-loss-drugs-glp-1-bridge-program-cost-estimate/ By Bob HermanJune 1, 2026 Bob Herman is the author of Health Care Inc., an award-winning weekly newsletter about the business of health and medicine.

Executives reveal tech initiatives at Summa Health, eight months after General Catalyst acquisition The VC firm said it hoped to use the Ohio safety-net hospital as a test bed for new technologies

https://www.statnews.com/2026/06/01/summa-health-tech-initiatives-after-general-catalyst-acquisition/ By Brittany TrangJune 1, 2026 Health Tech Reporter

CMS Medicare Fraud Prevention Week Webinar June 4, 2026: 2 - 3 PM ET / 1 - 2 PM CT

https://events.gcc.teams.microsoft.com/event/3cf72eac-25c0-4356-a084-e9ca1c626635@fbdcedc1-70a9-414b-bfa5-c3063fc3395e?utm_medium=email&utm_source=govdelivery Join us for the CMS Medicare Fraud Prevention Week, hosted by CMS Regions 1 and 3 (Boston and Philadelphia), where we highlight CMS's ongoing efforts to protect Medicare beneficiaries, safeguard taxpayer dollars, and strengthen the integrity of the Medicare programs. This webinar provides an essential introduction to Medicare fraud, waste, and abuse prevention equipping beneficiaries, caregivers, and community partners with the knowledge and tools they need to identify, report, and help stop healthcare fraud.

CDC's Clinical Drug Test Dashboard: Live Demo + Q&A June 11, 2026: 1 - 1:45 PM ET / 12 - 12:45 PM CT

https://events.gcc.teams.microsoft.com/event/58f24496-83ae-45fe-92f8-ecc1cdc0171b@9ce70869-60db-44fd-abe8-d2767077fc8f?ACSTrackingID=USCDC_1026-DM154569&ACSTrackingLabel=CDC+Launches+the+New+Clinical+Drug+Test+Dashboard+&deliveryName=USCDC_1026-DM154569&utm_medium=email&utm_source=govdelivery Join us for a brief webinar introducing CDC’s new data dashboard for tracking trends in illegally made fentanyl, heroin, cocaine, and methamphetamine use based on clinical urine drug testing data. This session will include a live demonstration of the dashboard’s features, along with a walkthrough of how to explore and interpret emerging patterns in substance use. We will conclude with a Q&A to address your questions and discuss how this tool can support data-driven decision-making.